Abstract:Objectives Diabetes is highly prevalent worldwide, with an estimated 536 million living with diabetes in 2021, and that number projected to increase to 783 million by 2045. Diabetic bladder dysfunction is thought to affect up to 60%–90% of individuals with diabetes and can significantly impact quality of life. Despite the prevalence of diabetic bladder dysfunction, the exact pathophysiological mechanism, and resulting clinical presentation, remains debated. Our objective was to compare urodynamic parameters between diabetic and nondiabetic women, assessing the impact of various markers of diabetes severity on bladder function. Methods A retrospective chart review was conducted on female patients aged 18 and above who underwent urodynamic studies at a single tertiary care university hospital system from 2014 to 2020. Patients were categorized based on diabetes status, and diabetes severity including duration of disease, hemoglobin A1c levels, insulin dependence, and markers of end‐organ dysfunction. Urodynamic variables, including compliance, bladder voided efficiency, bladder contractility index, postvoid residual, maximum flow rate, capacity, voided volume, and detrusor overactivity, were assessed by two independent reviewers. Statistical analyses were performed to assess the impact of diabetes and diabetic severity on urodynamic parameters. Results A total of 652 female patients were included in the study, of which, 152 (23.3%) had diabetes, with an average duration of diagnosis of 82.3 months. Diabetic women were older and had higher body mass index compared to nondiabetic women. Diabetic retinopathy and neuropathy were present in 18% and 54.6% of diabetic patients, respectively. Significant differences in urodynamic parameters were observed between diabetic and nondiabetic women, with diabetic women showing higher rates of detrusor overactivity (p = 0.01), particularly associated with increasing BMI (p = 0.03). However, classic markers of diabetes severity including duration, as well as markers of end‐organ damage, showed mixed associations with urodynamic changes. Conclusions Despite the prevalence of diabetic bladder dysfunction and its impact on patient quality of life, the exact mechanisms and clinical presentation remain elusive. Our study highlights the significant differences in urodynamic parameters between diabetic and nondiabetic women, emphasizing the need for further research into the relationship between diabetes and diabetic bladder dysfunction.

[Urodynamic Studies on Benign Prostatic Hyperplasia Combined with Diabetes Mellitus].

The Significance of Urodynamic Examination for Patients with Benign Pro-static Hyperplasia and Diabetes

A comparative study of two means of simultaneous treatment for benign prostate hyperplasia and bladder stone

Urodynamics and ultrastructure of detrusor in patients with benign prostatic hyperplasia

Correlation of Diabetes Control with Benign Prostatic Hyperplasia in T2DM Patients

The Relationship Between the Clinical Progression of Benign Prostatic Hyperplasia and Metabolic Syndrome: A Prospective Study

Clinical study the relationship between symptomatic parameters of benign prostate hyperplasia and sexual function

The value of pressure-flow study in diagnosis for patients with benign prostatic hyperplasia

Correlation Between Metabolic Syndrome and Clinical Progression in Patients with Benign Prostatic Hyperplasia

The correlation Study among lower urinary tract symptoms, benign prostatic hyperplasia and erectile dysfunction

Relationship between metabolic syndrome and benign prostatic hyperplasia

The urodynamics study in patient with chronic prostatitis(Report of 32 cases)

Dustarin in the Treatment of Patients with Benign Prostatic Hyperplasia

An analysis of urodynamic parameters in diabetic and nondiabetic women

The Correlation Between Metabolic Syndrome and Benign Prostatic Hyperplasia in Men over 50 Years O1d

Evaluation of detrusor function with urodynamics and treatment choice

Clinical analysis of BPH and BPH with chronic prostatitis

Analysis of platelet and monocyte-to-lymphocyte ratio and diabetes mellitus with benign prostatic enlargement

Relationship Between Benign Prostatic Hyperplasia and Metabolic Syndrome

The urodynamics study in 32 patients with chronic prostatitis

Urodynamic Manifestation of Patients with Chronic Refractory Prostatitis and Its Therapeutic Guiding Value